UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Molecular psychiatry, 2013-05, Vol.18 (5), p.543-556

2013

Volltextzugriff (PDF)

Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators

British journal of pharmacology, 2011-09, Vol.164 (2b), p.521-537

2011

Volltextzugriff (PDF)

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX2 receptor

British journal of pharmacology, 2009-04, Vol.156 (8), p.1326-1341

2009

Volltextzugriff (PDF)

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK1 and NK3 receptors

British journal of pharmacology, 2011-02, Vol.162 (4), p.929-946

2011

Volltextzugriff (PDF)

Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs

Neuropharmacology, 2002-03, Vol.42 (3), p.414-420

2002

Volltextzugriff (PDF)

Central nervous system pharmacology of neuropeptide Y

Pharmacology & therapeutics (Oxford), 1995-01, Vol.65 (3), p.397-414

1995

Volltextzugriff (PDF)

Elements of cerebral microvascular ischaemia

Brain Research Reviews, 2001-08, Vol.36 (1), p.23-34

2001

Volltextzugriff (PDF)

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

Behavioural pharmacology, 1995-04, Vol.6 (3), p.215-222

1995

Volltextzugriff (PDF)

On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia

Neuropharmacology, 1999-09, Vol.38 (9), p.1299-1306

1999

Volltextzugriff (PDF)

Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety

Psychopharmacology, 2008-08, Vol.199 (3), p.389-402

2008

Volltextzugriff (PDF)

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX 2 receptor

British journal of pharmacology, 2009-04, Vol.156 (8), p.1326-1341

2009

Volltextzugriff (PDF)

CCK antagonists: Pharmacology and therapeutic interest

Pharmacology & therapeutics (Oxford), 1994, Vol.62 (3), p.267-282

1994

Volltextzugriff (PDF)

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol

Behavioural brain research, 1997-10, Vol.88 (1), p.43-49

1997

Volltextzugriff (PDF)

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK 1 and NK 3 receptors

British journal of pharmacology, 2011-02, Vol.162 (4), p.929-946

2011

Volltextzugriff (PDF)

Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay

Pharmacology, biochemistry and behavior, 1996-02, Vol.53 (2), p.411-416

1996

Volltextzugriff (PDF)

Effect of AMPA receptor modulators on hippocampal and cortical function

European journal of pharmacology, 2000-04, Vol.394 (1), p.85-90

2000

Volltextzugriff (PDF)

White matter ischaemia

Brain Research Reviews, 1999-12, Vol.31 (1), p.58-64

1999

Volltextzugriff (PDF)

Antinociceptive effects of neuropeptide Y and related peptides in mice

Brain research, 1996-06, Vol.724 (1), p.25-32

1996

Volltextzugriff (PDF)

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (20), p.8485-8490

2011

Volltextzugriff (PDF)

Role of opioids in peripheral analgesia

Life Sciences, 1992, Vol.51 (26), p.2009-2018

1992

Volltextzugriff (PDF)

Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABAB receptors

British journal of pharmacology, 2008-06, Vol.154 (4), p.797-811

2008

Volltextzugriff (PDF)

Unusual behavioral profile of alprazolam in squirrel monkeys

The Journal of pharmacology and experimental therapeutics, 1990-06, Vol.253 (3), p.1070

Wettstein, J G

1990

Volltextzugriff (PDF)

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression

The Journal of pharmacology and experimental therapeutics, 2015-04, Vol.353 (1), p.213-233

2015

Volltextzugriff (PDF)

Behavioral effects of acute and chronic buspirone

European journal of pharmacology, 1988-07, Vol.151 (2), p.341-344

Wettstein, Joseph G.

1988

Volltextzugriff (PDF)

Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI)

Progress in neuro-psychopharmacology & biological psychiatry, 1999-04, Vol.23 (3), p.533-544

1999

Volltextzugriff (PDF)

1 – 25 von 278

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(136)
Life Sciences & Biomedicine
(124)
Animals
(86)
Male
(62)
Biological And Medical Sciences
(61)
Humans
(55)
Medical Sciences
(45)
Pharmacology & Pharmacy
(44)
Female
(38)
Mice
(33)
Rats
(31)
Pharmacology. Drug Treatments
(30)
Neurosciences
(27)
Neurosciences & Neurology
(27)
Neuropharmacology
(26)
Psychology. Psychoanalysis. Psychiatry
(23)
Biochemistry & Molecular Biology
(21)
Dose-Response Relationship, Drug
(17)
Fundamental And Applied Biological Sciences. Psychology
(17)
Psychopharmacology
(17)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

Structural determinants of allosteric antagonism at metabotropic glutamate receptor 2: mechanistic studies with new potent negative allosteric modulators

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX2 receptor

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK1 and NK3 receptors

Neonatal nitric oxide synthase inhibition: social interaction deficits in adulthood and reversal by antipsychotic drugs

Central nervous system pharmacology of neuropeptide Y

Elements of cerebral microvascular ischaemia

Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures

On the effect of neonatal nitric oxide synthase inhibition in rats: a potential neurodevelopmental model of schizophrenia

Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety

Biochemical and behavioural characterization of EMPA, a novel high‐affinity, selective antagonist for the OX 2 receptor

CCK antagonists: Pharmacology and therapeutic interest

Disruption of latent inhibition in the rat by the 5-HT2 agonist DOI: effects of MDL 100,907, clozapine, risperidone and haloperidol

Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK 1 and NK 3 receptors

Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay

Effect of AMPA receptor modulators on hippocampal and cortical function

White matter ischaemia

Antinociceptive effects of neuropeptide Y and related peptides in mice

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

Role of opioids in peripheral analgesia

Characterization of (R,S)‐5,7‐di‐tert‐butyl‐3‐hydroxy‐3‐trifluoromethyl‐3H‐benzofuran‐2‐one as a positive allosteric modulator of GABAB receptors

Unusual behavioral profile of alprazolam in squirrel monkeys

Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression

Behavioral effects of acute and chronic buspirone

Selectivity of action of typical and atypical antipsychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI)

Suchergebnisse filtern